Related Experiment Videos
On the catch-up time method for analyzing cancer screening trials
Biometrics
|March 1, 1995
Summary
This study evaluates the "catch-up time" method for cancer screening trials, finding it can introduce bias. Adaptive tests are proposed to improve power and maintain accuracy in mortality analysis.
Area of Science:
- Biostatistics
- Epidemiology
- Clinical Trial Design
Background:
- Cancer screening trials face challenges with time-varying mortality ratios due to lag and dilution effects.
- Conventional analysis tools like the logrank test may lose power in these scenarios.
Purpose of the Study:
- To evaluate the bias and power properties of the "catch-up time" method proposed by Aron and Prorok.
- To investigate alternative adaptive tests for cancer screening trial analysis.
Main Methods:
- Simulated data resembling the Health Insurance Plan of Greater New York study cohort were used.
- Models for postdiagnosis survival were considered under both null (no screening effect) and alternative (screening effect) hypotheses.
- The bias and power of the catch-up time method were thoroughly evaluated.
Main Results:
- The catch-up time method can introduce significant bias into cancer screening trial analyses.
- The standard logrank test may be less powerful due to time-dependent effects.
- Adaptive tests were identified as potentially more effective.
Conclusions:
- The catch-up time method is not always reliable for analyzing cancer screening trial data.
- Adaptive statistical tests offer a promising alternative for maintaining test size and improving power in the presence of complex disease dynamics.